US 9212168
Hepatitis C virus inhibitors
granted A61KA61K31/496A61K31/5377
Quick answer
US patent 9212168 (Hepatitis C virus inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/496, A61K31/5377, A61K31/541, A61K45/06